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Abstract 
Although a number of effective psychotherapeutic treatments have been developed for 
borderline personality disorder (BPD), little is known about the mechanisms of change 
explaining the effects of these treatments. There is increasing evidence that impairments in 
mentalizing or reflective functioning—the capacity to reflect on the internal mental states of the 
self and others—are a central feature of BPD. To date, no study has directly investigated the core 
assumption of the mentalization-based approach to BPD, that changes in this capacity are 
associated with treatment outcome in BPD patients. This study is the first to directly investigate 
this assumption in a sample of 175 patients with BPD who received long-term hospitalization-
based psychodynamic treatment. Using a parallel process growth modeling approach, this study 
investigated whether (a) treatment was related to changes in mentalizing capacity as measured 
with the Reflective Functioning Questionnaire; (b) these changes could be explained by 
pretreatment levels of mentalizing and/or symptomatic distress; and (c) changes in mentalizing 
capacity over time were associated with symptomatic improvement. Mentalizing and 
symptomatic distress were assessed at admission, 12 and 24 weeks into treatment, and at 
discharge. Results showed that treatment was associated with significant decreases in 
mentalizing impairments (i.e., uncertainty about mental states) and symptomatic distress. 
Pretreatment levels of mentalizing and symptomatic distress did not predict these changes. 
However, improvements in mentalizing were strongly associated with the rate of decrease in 
symptomatic distress over time (r = .89). These findings suggest that increases in mentalizing 
may indeed in part explain therapeutic change in the treatment of BPD, but more research is 
needed to further substantiate the conclusions.  
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Borderline personality disorder (BPD) is described in DSM-5 (American Psychiatric 
Association, 2013) as a pervasive pattern of instability in interpersonal relationships, self-image, 
and affect, and marked impulsivity. The disorder is often comorbid with other mental illnesses 
and is related to high levels of self-harm and suicidality, resulting in large direct and indirect 
personal and economic costs ((Black, Blum, Pfohl, & Hale, 2004; Grant et al., 2008; Soeteman, 
Hakkaart-van Roijen, Verheul, & Busschbach, 2008). 
The mentalizing approach to BPD pathology has attracted increasing attention in the past 
two decades. Mentalizing or reflective functioning is a form of social cognition that refers to the 
capacity to reflect on internal mental states (e.g., feelings, wishes, attitudes, and goals) of the self 
and others (Choi-Kain & Gunderson, 2008; P Fonagy & Bateman, 2008; P Fonagy & Luyten, 
2009). Studies investigating mentalizing in BPD have found a paradoxical combination of 
hypersensitivity to emotional states of others based on their external features (e.g., facial 
expression) and gross impairments in the capacity to reflect on internal mental states of both self 
and others (P Fonagy & Luyten, 2009; Sharp & Vanwoerden, 2015). 
The mentalization-based approach to BPD provides a theoretically comprehensive 
framework for understanding BPD and has led to the development of Mentalization-Based 
Treatment (MBT) for BPD patients (P Fonagy & Bateman, 2008). In MBT, the focus is on 
strengthening patients’ mentalizing capacity, which is thought to improve affect regulation and 
interpersonal functioning (Fonagy & Bateman, 2006).  
Moreover, the mentalizing approach argues that mentalizing is a fundamental 
psychological process that functions as a common factor in treatments for BPD patients, and that 
improvement in mentalizing capacity is therefore a central mechanism of change in any 
successful treatment for BPD (Fonagy, Luyten, & Bateman, 2015). 
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Although there is some preliminary evidence for this latter assumption, no study to date 
has directly investigated whether changes in mentalizing capacity parallel improvements in 
symptoms and complaints. Antonsen, Johansen, Rø, Kvarstein and Wilberg (2016) for example, 
reported that impairments in mentalizing were associated with symptomatic and interpersonal 
distress, and lower psychosocial and personality functioning at baseline, but were not related to 
clinical outcome at 6-year follow-up. However, in this study, trajectories of change in 
mentalizing and outcome were not directly compared. Bo et al. (2016), in turn, reported that 
mentalization-based group therapy was associated with improvements in mentalizing in a sample 
of adolescent female BPD patients. Specifically, in a sample of 34 Danish, female adolescent 
(age 15-18 years) BPD patients, 1 year of structured mentalization-based group treatment was 
associated with improvements in both BPD symptoms, as measured with the Borderline 
Personality Features Scale for Children (BPFS-C, Crick, Murray-Close, & Woods, 2005), and in 
mentalizing, as measured with the Reflective Functioning Scale for Youth (RFQ-Y, Sharp et al., 
2009). Within-person changes from baseline to end of treatment were evaluated with paired 
sample t-tests. However, this study did not directly evaluate the association between 
improvements in mentalizing and improvement in outcome.  
The Present Study 
This study is the first to directly investigate the association between changes in reflective 
functioning and outcome in a sample of 175 BPD patients using data from a naturalistic study of 
the effectiveness of hospitalization-based treatment for BPD. Patients were assessed at four time 
points: at admission, 12 and 24 weeks into treatment, and at discharge. Mentalizing was 
measured using the Reflective Functioning Questionnaire (RFQ), a self-report questionnaire 
comprising two scales (Fonagy et al., 2016). The first scale assesses uncertainty about mental 
Running Head: MENTALIZING AS A MECHANISM OF CHANGE IN BPD 
6 
states (RFQ-U) and is assumed to capture hypomentalizing or an inability to create mental 
models of the mind of self and others. The second subscale captures individuals’ certainty about 
mental states (RFQ-C), which in the extreme characterizes hypermentalizing or excessive 
mentalizing (Fonagy et al., 2016). 
Using a parallel process multilevel growth modeling approach, this study investigated 
whether (a) there is a significant decrease in mentalizing problems and symptomatic distress over 
the course of treatment, (b) pretreatment levels of mentalizing are associated with symptomatic 
change, and (c) changes in mentalizing capacity are related to change in symptoms during 
treatment.  
Methods 
Participants and Procedure 
This study is part of a larger, ongoing process-outcome study. The data used in this study 
were collected between July 2010 and April 2014. During this period, 207 patients consecutively 
admitted to an intensive psychodynamic hospitalization-based treatment for personality disorders 
were studied. Inclusion criteria were (a) a principal diagnosis of a personality disorder given by a 
trained and experienced psychiatrist based on an extensive intake interview, and (b) Dutch 
literacy. Individuals with an acute psychotic episode or severe substance abuse were excluded. 
For this study, we selected only patients who fulfilled criteria for DSM-IV-defined BPD 
(American Psychiatric Association, 2000) based on the self-report questionnaire of the 
Structured Clinical Interview for DSM-IV Axis II disorders (SCID-II-SQ, Spitzer, Williams, 
Gibbon & First, 1990) (i.e., scores ≥5) that was administered at intake. This resulted in a sample 
of 175 BPD patients.  
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Their mean age was 30 years old (SD = 9.13) and 104 patients (59.4%) were female. The 
patients stayed in treatment for a mean of 6.76 months (SD = 4.56). Patients were relatively well 
educated: most of them (82.9%) completed secondary school and 48.6% completed some form 
of higher education (20% had a university degree). Thirty three percent of the patients lived 
alone, 35.4% lived with their parents, and 23.8% were married or living with a partner. 
Comorbidity of BPD with symptom disorders as assessed with the Psychiatric Diagnostic 
Screening Questionnaire (PDSQ; Zimmerman & Mattia, 2001) was high. The most commonly 
reported psychiatric symptoms were depression (82.8% of patients scoring above the clinical 
cutoff), social phobia (79.5%), generalized anxiety disorder (78.2%) and somatization (63.6%). 
Comorbid personality disorders were assessed with SCID-II-SQ. Comorbidity in this sample was 
very high, with 80% of patients scoring above the cutoff for more than 4 different personality 
disorders. Depressive (83%), avoidant (80.7%) and obsessive-compulsive (73.3%) personality 
disorder were most common.  
After receiving an explanation about the study (provided by a research assistant) and 
giving informed consent, patients entered the study and were assessed at admission, 12 and 24 
weeks into treatment, and at discharge. This study was approved by the ethical committee of KU 
Leuven. 
Treatment 
The treatment provided has been described in detail elsewhere (Vermote, Lowyck, & 
Vandeneede, 2011). It is an intensive, hospitalization-based treatment for patients with 
personality disorder, consisting of the following elements: (a) group psychodynamic 
psychotherapy (three times a week), (b) nonverbal therapies (music therapy, psychomotor 
therapy, and creativity therapy, each twice a week), (c) family therapy (on indication), (d) 
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psychiatric consultation, (e) weekly individual sessions with a nurse, (f) group sessions with 
nurses (twice a week), (g) social work, and (h) a weekly patient–staff meeting. The treatment 
focuses on three central features of patients with (borderline) personality disorder: (a) difficulties 
with trust, (b) mentalizing impairments, and (c) impairments in the capacity for relatedness. It 
integrates mentalization-based interventions and principles with more traditional, insight-
oriented psychoanalytic work. 
Measures 
Reflective Functioning Questionnaire (RFQ). The RFQ (Fonagy et al., 2016) is a self-
report measure for reflective functioning or mentalizing. The RFQ consists of eight items in total 
that are answered on a 6-point Likert scale, ranging from 1 (I do not agree at all) to 6 (I very 
much agree). The RFQ has two subscales, Certainty and Uncertainty, each containing six items. 
Four items are used to calculate scores on both subscales, while the other four items are unique 
to each subscale (see below, and see Fonagy et al., 2016, for a detailed description).  
Specifically, the items of the RFQ_Uncertainty (RFQ-U) scale are rescored so that high 
scores reflect extreme uncertainty about mental states, assumed to assess hypomentalizing. For 
example, the item “Sometimes I do things without really knowing why” is recoded 0, 0, 0, 0, 1, 2, 
since strong agreement reflects a lack of knowledge about mental states. The items of the 
RFQ_Certainty (RFQ-C) subscale are rescored to capture certainty about mental states. For 
example, “I don’t always know why I do what I do” is recoded 2, 1, 0, 0, 0, 0, because strong 
disagreement with this statement reflects more certainty about mental states. While the RFQ-U 
scale has been consistently positively related to other measures assessing impairments in 
mentalizing (such as alexithymia) and to measures of personality pathology, findings with the 
RFQ-C scale suggest that it taps into both adaptive and maladaptive features of mentalizing. For 
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example, the RFQ-C scale has been shown to be positively related to eating disorder symptoms, 
but also to empathy, and negatively to alexithymia (Badoud et al., 2015; Fonagy et al., 2016). 
Furthermore, the RFQ-U scale and, to a somewhat lesser extent, the RFQ-C scale have been 
found to distinguish between normal controls and BPD patients. The internal consistency for 
both RFQ-U and RFQ-C was good, with Cronbach’s alpha values of 0.77 and 0.65, and test–
retest reliability over 3 weeks was very good, with rs = 0.84 and 0.75 for RFQ-U and RFQ-C, 
respectively (Fonagy et al., 2016). In this study, Cronbach’s alpha values were 0.68 for RFQ-U 
and 0.70 for RFQ-C at baseline. 
Brief Symptom Inventory. The Dutch version of the Brief Symptom Inventory, the 
Korte Klachten Lijst (KKL, Lange & Appelo, 2007), is a self-report questionnaire measuring 
symptomatic distress experienced in the past week, expressed in the following domains: anxiety, 
memory difficulties, depressive feelings, somatic complaints, irritability, suicidal thoughts, 
problems in relational functioning, eating disorders, self-harm, sexual problems, sleeping 
problems, and substance abuse. The questionnaire consists of 13 questions, scored on a 5-point 
Likert scale, ranging from 0 (no complaints) to 4 (many complaints). The total score (ranging 
from 0–52) was calculated by summing the scores for individual questions. The validity and 
reliability of the inventory have proven to be satisfactory (Lange & Appelo, 2007). In this study, 
the internal consistency of the KKL at baseline was α = 0.75. 
SCID-II-SQ. BPD was assessed using a self-report version of the SCID-II (SCID-II-SQ; 
Spitzer et al., 1990). The SCID-II-SQ consists of 119 yes-or-no questions based on the 
diagnostic criteria of DSM-IV Axis II. In accordance with the interview version of the SCID-II, a 
cut-off score (5 or more out of 15 items) for the BPD scale was applied. The agreement between 
the SCID-II-SQ and the SCID-II interview in terms of number of criteria fulfilled was found to 
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be high (r = 0.84; Ekselius, Lindström, Knorring, Bodlund, & Kullgren, 1994). There was 
adequate test–retest reliability (Ouimette & Klein, 1995) and the internal consistency of the 
SCID-II-SQ in this study was very good (α = 0.89). 
PDSQ. The Psychiatric Diagnostic Screening Questionnaire (PDSQ; Zimmerman & 
Mattia, 2001) is a self-report questionnaire consisting of 126 items that can be used to screen for 
common DSM-IV Axis I psychiatric disorders. The psychometric quality of the PDSQ has been 
established in two large-scale validation studies (Zimmerman and Chelminsky, 2006; 
Zimmerman and Mattia, 2001). The total score of the PDSQ was found to be highly reliable in 
the present study (α=0.96). 
 
Data Analysis 
This study applied a multivariate multilevel parallel growth model for change 
(MacCallum, Kim, Malarkey, & Kiecolt-Glazer, 1997; Singer & Willett, 2003) with repeated 
measurements nested within subjects to study (a) whether mentalizing capacity and symptoms 
change over the course of treatment, (b) whether pretreatment mentalizing and symptomatic 
distress are predictive of changes in symptomatic distress over the course of treatment, and (c) 
whether the process of change in mentalizing and symptomatic distress are related to one 
another. The first three assessments were scheduled at the same times for all patients: at 
admission/baseline, after 12 weeks (3 months), and after 24 weeks (6 months). The final 
assessment, at discharge, was variable. In the model mentioned above, time is a continuous 
variable expressed in terms of months since admission (see Appendix 1 for more details). 
Two separate models were estimated for RFQ-C and symptomatic distress on the one 
hand, and for RFQ-U and symptomatic distress on the other hand. The best-fitting model for 
Running Head: MENTALIZING AS A MECHANISM OF CHANGE IN BPD 
11 
each of the different outcome variables was selected on the basis of graphical inspection of the 
data, likelihood ratio tests, and information criteria (Bryk & Raudenbush, 1992; Singer & 
Willett, 2003; Verbeke & Molenberghs, 2000). For RFQ-C, a model with random subject-
specific intercepts and a fixed linear slope for time was selected. For RFQ-U, a model with 
random subject-specific intercepts and random subject-specific linear slopes for time was 
selected. Finally, for symptomatic distress, a model with random subject-specific intercepts, 
random subject-specific linear slopes for time, and a fixed quadratic term for time was used.  
Individual differences in patterns of change of mentalizing and symptoms over the course 
of treatment were studied by examining the fixed effects and the covariance parameters of the 
random subject-specific intercept and slope parameters of the involved variables. To investigate 
the parallel processes of the different variables, the model yielded not only estimates of fixed 
effects, random variance parameters, random covariance parameters, and error terms for each 
outcome variable separately (see research question (a)), but also random covariances for 
parameters representing different outcome variables (see research questions (b) and (c)). For 
example, the covariance between the random subject-specific slopes for time for RFQ-U on the 
one hand, and the random subject-specific slopes for time for symptomatic distress on the other 
hand, indicates whether subjects are characterized by the same linear change over time on both 
outcome variables. It should be noted that, as missing data are almost inevitable in longitudinal 
studies, inference for the proposed models is valid under the assumption of missingness at 
random (Little & Rubin, 2002). All models were estimated using SAS version 9.4 (Statistical 
Analysis Software, SAS Institute Inc., Cary, NC, USA). 
Finally, effect sizes were calculated to evaluate treatment effects using pre–post 
standardized mean gain scores (Becker, 1988). These scores can be interpreted in the same way 
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as Cohen’s d (Cohen, 1988): d ≤ 0.20 is considered a small effect size, d ≈ 0.50 a medium effect 
size, and d ≥ 0.80 a large effect size.  
Results 
Relationship between Mentalizing and Symptomatic Distress at Baseline 
As shown in Table 1, levels of uncertainty about mental states (RFQ-U) were 
significantly related to symptomatic distress (KKL) at baseline (r = 0.45, p < 0.001). Levels of 
certainty about mental states (RFQ-C) were, however, not related to symptomatic distress at 
baseline (Table 2; r = -0.17, p = 0.15). 
Changes in Mentalizing and Symptomatic Distress during Treatment 
Levels of uncertainty about mental states (RFQ-U) decreased linearly and significantly 
during treatment (Table 3; β = -0.13, SE = 0.03, p < .0001; see thick average line in Figure 1a). 
There were substantive individual differences both in the level of RFQ-U at baseline (i.e. the 
intercepts) and in the decrease in RFQ-U during treatment (i.e. the slopes), as shown in Figure 
1a. The pre–post treatment standardized mean gain score for RFQ-U had a medium effect size of 
0.52. The model for the levels of certainty about mental states (RFQ-C) had random intercepts 
and a fixed (but nonsignificant) slope for time. As a result, there were individual differences in 
the RFQ-C at baseline but not in the change—either on average, or individually—of RFQ-C over 
time (Table 4; β = 0.009, SE = 0.02, p = 0.63). In line with these results, the pre–post treatment 
effect size for RFQ-C was -0.10.  
Symptomatic distress decreased significantly over the course of treatment; however, a 
quadratic effect of time was observed, which indicates that the linear decrease of symptoms over 
the course of treatment leveled off toward the end (Table 3; β for time = -1.25, SE = 0.20, p < 
.0001; β for time² = 0.04, SE = 0.02, p = 0.02; see thick average line in Figure 1b). There were 
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also substantive individual differences both in symptomatic distress at baseline and in the linear 
decrease of symptoms during treatment (Figure 1b). The pre–post standardized treatment main 
gain score was large (d = 1.07). 
Role of Pretreatment Levels of Mentalizing and Symptomatic Distress on Rate of Change 
during Treatment  
Results showed no significant associations between patient-specific (PS) intercepts of 
RFQ-U and PS slopes of KKL, which indicates that pretreatment levels of RFQ-U were not 
associated with changes in symptoms during treatment (see Table 1). There was, however, a 
trend toward significance (r = -0.40, p = 0.07) of associations between pretreatment levels of 
RFQ-U and changes in RFQ-U. In other words, there was a tendency for patients with higher 
levels of RFQ-U at baseline to show a faster decrease of RFQ-U during treatment and for 
patients with lower RFQ-U at baseline to show a lower decrease during treatment. 
As shown in Table 2, pretreatment levels of RFQ-C did not predict changes in symptoms. 
Similarly, no association was found between pretreatment levels of symptomatic distress and 
changes in symptoms during treatment.  
Mentalizing and Symptomatic Distress over the Course of Treatment 
As shown in Table 1, with regard to RFQ-U, results showed a strong and highly 
significant positive correlation between PS slopes for RFQ-U and PS slopes for symptomatic 
distress (r = .89, p = 0.01). In other words, a linear decrease in RFQ-U was associated with a 
decrease in symptomatic distress during treatment.  
To illustrate this finding, the parallel process between level of RFQ-U and symptomatic 
distress is plotted for four patients in Figure 2. Patients who showed a strong decrease in RFQ-U 
(e.g., patients 3 and 4 in Figure 2a) also showed a strong decrease in symptoms (Figure 2b), 
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whereas patients who showed less or no reduction in RFQ-U (e.g., patients 1 and 2 in Figure 2a) 
also showed a smaller reduction in symptomatic distress (Figure 2b). 
Results showed no change in RFQ-C during treatment either on average or at an 
individual patient level. As a result, there was no evidence for a parallel process between RFQ-C 
and symptomatic distress, as RFQ-C did not change over time.  
Discussion 
Findings of this study suggest that an increase in the capacity for mentalizing in the 
course of an intensive specialized treatment explained in part changes in symptomatic distress, 
consistent with the assumptions of mentalization-based approaches to BPD.  
In particular, results showed that treatment was associated with a significant decrease in 
uncertainty about mental states (hypomentalizing), which indicates an improved capacity to 
reflect on the internal mental states of the self and others. However, in contrast to the 
mentalization-based approach to BPD (Fonagy & Bateman, 2008), the current treatment was not 
associated with a decrease in certainty about mental states. On the one hand, this could mean that 
there was no improvement in hypermentalizing, which is typical of many BPD patients (Sharp & 
Vanwoerden, 2015). However, it could also be the case that the RFQ-C scale of the RFQ does 
not succeed in capturing the excessive certainty about mental states that is assumed to 
characterize hypermentalizing in BPD. As noted, previous research with the RFQ has shown that 
scores on the RFQ-C were related to eating disorder symptoms, which have been associated with 
a tendency toward hypermentalizing (Fonagy et al., 2016; Skårderud, 2007). However, the RFQ-
C score has also been inversely related to borderline symptoms, depressive symptoms, and 
severity of personality pathology (Fonagy et al., 2016). For this reason, it remains somewhat 
unclear whether the RFQ-C assesses hypermentalizing or whether it also partly captures features 
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of genuine mentalizing. Further studies are needed to investigate the relationship between the 
RFQ-C subscale and other measures of hypermentalizing, such as the excessive theory of mind 
scale of the Movie Assesssment for Social Cognition (MASC; Dziobek et al., 2006; Sharp & 
Vanwoerden, 2015). 
Furthermore, pretreatment levels of mentalizing (as well as symptomatic distress) did not 
predict symptom change over the course of treatment. So, even though there were substantial 
individual differences between BPD patients in symptom change, suggesting that the treatment 
was more effective for some patients than for others, these differences could not be predicted by 
the variables included in this study. There was, however, a tendency for patients with higher 
levels of RFQ-U at baseline to show a faster decrease in RFQ-U score during treatment, 
suggesting that the patients’ mentalizing capacity at the start of treatment did have an effect on 
how fast their mentalizing capacity improved during treatment. As this finding might reflect 
regression to the mean, further research is needed to replicate these findings. 
Finally, and most importantly, results showed that the rate of decrease in RFQ-U was 
associated with the rate of decrease in symptoms, indicating that improvement in mentalizing 
capacity coincides with improvement in symptoms. This relationship was very strong (r = 0.89). 
Although further research is needed to replicate this finding, the improved capacity to reflect on 
internal mental states of oneself and others (expressed as less uncertainty about mental states) 
appears to make patients feel better in terms of experienced symptoms over the course of 
treatment. Together, these findings suggest that mentalizing may be an important mechanism of 
change in the treatment of BPD patients. 
Despite its strengths, this study had several important limitations. First, the primary 
outcome was a brief self-report measure of general symptomatic distress in general (the KKL) 
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rather than specific BPD pathology. Although this measure includes some characteristic BPD 
symptoms, such as self-harm, suicidality, and interpersonal problems, future studies should 
include a more direct measure of BPD features as primary outcome. In spite of this limitation, 
the study results are nevertheless informative for both research and clinical practice, particularly 
as a number of studies have suggested that general symptomatic distress may be a good proxy of 
the general severity of personality disorder pathology, the so-called psychopathology or ‘p’ 
factor (Caspi et al., 2014; Patalay et al., 2015). Second, there was no control group in this study, 
and so it is impossible to rule out the possibility that the effects may be due to factors other than 
the treatment itself. Third, BPD diagnosis was based on patients’ self-report on the SCID-II-SQ 
(after clinical diagnosis of a personality disorder by a psychiatrist). Although there is some 
evidence suggesting high concordance with interview-based measures of personality disorder 
diagnosis (Ekselius et al., 1994), the reliance on patients’ self-reported BPD symptoms may have 
led to an overestimation of the true prevalence of BPD. Finally, mentalizing was assessed using 
only a self-report questionnaire. It would be interesting to see whether the treatment results in 
improved performance on other measures of mentalizing (e.g., the Movie for the Assessment of 
Social Cognition, Dziobek et al., 2006) and whether these improvements also predict outcome. 
Furthermore, the use of self-report questionnaires to measure both the outcome (symptomatic 
distress) and the mechanism of change (mentalizing) in this study may have inflated their 
association due to shared method variance. Finally, this study does not allow us to determine the 
relative importance of mentalizing as a mechanism of change because there was no assessment 
of other putative mechanisms of change. 
Further studies are thus needed to investigate to what extent these findings may 
generalize to other treatments. The fact that the treatment in the current study resulted in changes 
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in mentalizing, however, provides some preliminary evidence that mentalizing may be a 
common factor producing therapeutic change in any successful intervention for BPD (Fonagy et 
al., 2015).  
In conclusion, the results of this study show that in BPD patients, intensive 
hospitalization-based psychodynamic treatment is associated with significant improvements in 
mentalizing capacity expressed as less uncertainty about mental states, which coincides with, and 
may lead to, important reductions in symptomatic distress in these patients. 
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Table 1. Correlation matrix for the random effects (i.e., patient-specific slopes and patient-
specific intercepts) of a multivariate multilevel model for change: Uncertainty about Mental 
States and Symptomatic Distress. 
 
 
 RFQ-U 
Symptomatic Distress 
(KKL) 
  
PS 
intercepts 
PS 
slopes 
PS 
intercepts 
PS 
slopes 
RFQ-U PS-intercepts 1 -0.40 0.45*** -0.05 
 PS-slopes  1 -0.25 0.89** 
Symptomatic  
Distress (KKL) 
PS-intercepts   1 0.03 
PS-slopes    1 
Note: RFQ-U = Reflective Functioning Questionnaire – Uncertainty subscale, KKL= Korte 
Klachten Lijst, PS = patient-specific, ** p < .01;*** p < .001. 
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Table 2. Correlation matrix of the random effects (i.e., patient-specific slopes and patient-
specific intercepts) of a multivariate multilevel model for change: Certainty about Mental States 
and Symptomatic Distress. 
  RFQ-C Symptomatic Distress (KKL) 
  PS-intercepts PS-intercepts PS-slopes 
RFQ-C PS-intercepts 1 -0.17 -0.40 
Symptomatic 
Distress (KKL) 
PS-intercepts  1 0.10 
PS-slopes   1 
Note: RFQ-C = Reflective Functioning Questionnaire – Certainty subscale, KKL= Korte 
Klachten Lijst, PS = patient-specific, ** p < .01;*** p < .001. 
 
 
  
Running Head: MENTALIZING AS A MECHANISM OF CHANGE IN BPD 
25 
Table 3. Regression coefficients for the fixed effects in a multivariate multilevel model for 
change: Uncertainty about Mental States and Symptomatic Distress 
Fixed Effects Regression Coefficients (SE) 
 RFQ-U Symptomatic Distress (KKL) 
Overall intercept 4.18 (0.20) *** 26.28 (0.65) *** 
Past months (linear) -0.13 (0.03) *** -1.25 (0.20) *** 
(Past months)2 (quadratic) NA 0.04 (0.02) * 
Note: RFQ-U = Reflective Functioning Questionnaire – Uncertainty subscale, KKL= Korte 
Klachten Lijst, NA = Not applicable; * p < 0.05, *** p < .001. 
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Table 4. Regression coefficients for the fixed effects in a multivariate multilevel model for 
change: Certainty about Mental States and Symptomatic Distress. 
Fixed Effects Regression Coefficients (SE) 
 RFQ-C Symptomatic Distress 
Overall intercept 1.67 (0.15) *** 26.27 (0.65)*** 
Past months (linear) 0.009 (0.02) -1.27 (0.20)*** 
(Past months)2 (quadratic) NA 0.04 (0.02) ** 
Note: RFQ-C = Reflective Functioning Questionnaire – Certainty subscale, KKL= Korte 
Klachten Lijst ,** p < 0.01*** p < .001; NA = Not applicable;. 
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(a) Change in RFQ-U score during treatment. 
 
(b) Change in KKL score during treatment.
 
Figure 1. Average (thick black line) and patient-specific (thin black lines) changes in scores of 
50 randomly selected patients for (a) RFQ-U and (b) symptomatic distress (KKL) during 
treatment. 
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(a) Patient-specific change in RFQ-U score during treatment.  
 
 
(b) Patient-specific change in symptomatic distress during treatment. 
 
Figure 2. Change in (a) RFQ-U score and (b) symptomatic distress (KKL) score during 
treatment for four individual patients. 
 
